Jefferies Financial Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $261K | Buy |
+2,500
| New | +$261K | ﹤0.01% | 811 |
|
|
2025
Q1 | – | Sell |
-40,700
| Closed | -$3.44M | – | 1345 |
|
|
2024
Q4 | $3.44M | Buy |
+40,700
| New | +$3.44M | 0.02% | 357 |
|
|
2024
Q3 | – | Sell |
-15,859
| Closed | -$1.28M | – | 1131 |
|
|
2024
Q2 | $1.28M | Sell |
15,859
-316,907
| -95% | -$25.5M | 0.01% | 491 |
|
|
2024
Q1 | $26.6M | Sell |
332,766
-230,569
| -41% | -$18.4M | 0.25% | 33 |
|
|
2023
Q4 | $44.8M | Buy |
563,335
+10,140
| +2% | +$807K | 0.29% | 12 |
|
|
2023
Q3 | $38.7M | Buy |
+553,195
| New | +$38.7M | 0.35% | 11 |
|